Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.007 | 0.2512 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1 | 0.398 |
Brugia malayi | beta-NAC-like protein | 0.007 | 0.2512 | 1 |
Trypanosoma cruzi | transcription factor btf3, putative | 0.007 | 0.2512 | 1 |
Mycobacterium leprae | PROBABLE CONSERVED LIPOPROTEIN LPQF | 0.0062 | 0.2172 | 1 |
Brugia malayi | beta-lactamase | 0.0037 | 0.1 | 0.398 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1 | 0.398 |
Echinococcus granulosus | transcription factor btf3 | 0.007 | 0.2512 | 1 |
Mycobacterium tuberculosis | Class a beta-lactamase BlaC | 0.013 | 0.5252 | 0.4724 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0037 | 0.1 | 0.217 |
Brugia malayi | beta-lactamase family protein | 0.0037 | 0.1 | 0.398 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1 | 0.398 |
Entamoeba histolytica | transcription factor BTF3, putative | 0.007 | 0.2512 | 0.5 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0037 | 0.1 | 0.217 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0581 | 0.2312 |
Toxoplasma gondii | NAC domain-containing protein | 0.007 | 0.2512 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1 | 0.398 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0037 | 0.1 | 0.217 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0027 | 0.0581 | 0.2312 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0558 | 0.2221 |
Trichomonas vaginalis | conserved hypothetical protein | 0.007 | 0.2512 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1 | 0.398 |
Leishmania major | basic transcription factor 3a, putative | 0.007 | 0.2512 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0027 | 0.0581 | 0.2312 |
Brugia malayi | beta-lactamase family protein | 0.0037 | 0.1 | 0.398 |
Loa Loa (eye worm) | beta-lactamase | 0.0037 | 0.1 | 0.398 |
Schistosoma mansoni | transcription factor btf3 | 0.007 | 0.2512 | 1 |
Echinococcus multilocularis | transcription factor btf3 | 0.007 | 0.2512 | 1 |
Mycobacterium ulcerans | class a beta-lactamase, BlaC | 0.013 | 0.5252 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.007 | 0.2512 | 1 |
Loa Loa (eye worm) | ICD-1 protein | 0.007 | 0.2512 | 1 |
Onchocerca volvulus | 0.0037 | 0.1 | 1 | |
Onchocerca volvulus | 0.0037 | 0.1 | 1 | |
Plasmodium falciparum | basic transcription factor 3b, putative | 0.007 | 0.2512 | 0.5 |
Mycobacterium tuberculosis | Probable conserved lipoprotein LpqF | 0.0062 | 0.2172 | 0.1303 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0037 | 0.1 | 0.217 |
Trypanosoma brucei | transcription factor BTF3, putative | 0.007 | 0.2512 | 1 |
Plasmodium vivax | basic transcription factor 3b, putative | 0.007 | 0.2512 | 1 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0037 | 0.1 | 0.398 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1 | 0.398 |
Entamoeba histolytica | hypothetical protein | 0.007 | 0.2512 | 0.5 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0037 | 0.1 | 0.398 |
Mycobacterium ulcerans | lipoprotein LpqF | 0.0062 | 0.2172 | 0.2758 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0027 | 0.0581 | 0.2312 |
Trypanosoma brucei | beta lactamase | 0.0062 | 0.2172 | 0.7752 |
Onchocerca volvulus | 0.0037 | 0.1 | 1 | |
Brugia malayi | intermediate filament protein | 0.0027 | 0.0581 | 0.2312 |
Trypanosoma cruzi | transcription factor btf3, putative | 0.007 | 0.2512 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 30 uM | In vitro inhibitory concentration that relaxed KCL induced contraction in rat detrusor strip by 50% | ChEMBL. | 10737753 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.